Formyl Peptide Receptor-2-Suppressed Autophagy Promotes the Migration and Invasion of Human Glioblastoma Cells

Zhenzhao Luo1, Deyong Kong1, Guangjian Qi2

  • 1Department of Medical Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 4300014, China.

Insights

Formyl peptide receptor-2 (FPR2) promotes glioblastoma (GBM) invasion by suppressing autophagy and activating PI3K/AKT signaling. Inhibiting FPR2 or inducing autophagy may offer new therapeutic strategies for GBM.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Formyl peptide receptor-2 (FPR2), a G protein-coupled receptor (GPCR), is implicated in tumor development.
  • The specific roles and mechanisms of FPR2 in glioblastoma (GBM) are not well understood.

Purpose of the Study:

  • To investigate the role and mechanism of FPR2 in glioblastoma.
  • To explore the potential of targeting FPR2 or modulating autophagy for GBM therapy.

Main Methods:

  • Western blot analysis to assess protein expression and signaling pathways.
  • In vitro and in vivo experiments involving FPR2 knockdown in GBM cells.
  • Analysis of cell cycle, apoptosis, and autophagy markers (BECN1, ATG5).

Main Results:

  • FPR2 is upregulated in glioma tissues and cell lines, correlating with poor survival.
  • FPR2 suppresses autophagy and activates the PI3K/AKT pathway in GBM cells.
  • FPR2 knockdown reduces GBM cell migration, invasion, and tumor growth, inducing G2/M cell cycle arrest and apoptosis.
  • FPR2 prevents autophagy-induced degradation of Snail, inhibiting epithelial-mesenchymal transition (EMT)-like changes.

Conclusions:

  • FPR2 promotes GBM cell migration and invasion by inhibiting autophagy and activating PI3K/AKT signaling.
  • Targeting FPR2 or inducing autophagy represents a potential therapeutic strategy for GBM treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K